Ozempic vs Saxenda: Which GLP-1 Drug Is Better for Weight Loss?

Ozempic vs Saxenda: Which GLP-1 Drug Is Better for Weight Loss?

Ozempic and Saxenda are often mentioned in the same conversation because both are GLP-1 medicines that can reduce appetite and support weight loss. But they are not the same drug, they are not taken the same way, and they do not have the same weight-loss results in clinical trials.

If you want the short version: semaglutide has generally produced more weight loss than liraglutide in head-to-head research, but that does not automatically mean Ozempic is the right choice for every person. Safety, tolerability, insurance, indication, and injection schedule still matter a lot.

This guide compares the two in a practical way, using current prescribing information and major trial data available as of May 8, 2026. Consult your healthcare provider before starting any medication.

What is the difference between Ozempic and Saxenda?

Active ingredient

• Ozempic contains semaglutide
• Saxenda contains liraglutide

Both are GLP-1 receptor agonists, but semaglutide lasts longer in the body, which is a big reason the dosing schedule is different.

Injection schedule

This is one of the most noticeable real-life differences:

• Ozempic is injected once weekly
• Saxenda is injected once daily

For many people, weekly dosing feels easier to stick with than a daily injection routine.

What each brand is approved for

This is an important nuance.

• Ozempic is FDA-approved for type 2 diabetes and to reduce certain cardiovascular and kidney risks in adults with type 2 diabetes and chronic kidney disease, depending on the indication in the current label.
• Saxenda is FDA-approved for chronic weight management in eligible adults and certain pediatric patients.

For weight loss specifically, semaglutide’s dedicated obesity brand is Wegovy, not Ozempic. But because Ozempic and Wegovy share the same active ingredient, people often compare Ozempic with Saxenda in practical discussions about weight loss.

How do they help with weight loss?

Both drugs mimic GLP-1, a hormone involved in appetite and blood sugar regulation. In practical terms, they can help by:

• reducing appetite
• increasing fullness after eating
• slowing stomach emptying
• making it easier to eat smaller portions

That shared mechanism is why both can help with weight reduction. The difference is in how strongly and how consistently they do it at approved doses.

Which one causes more weight loss?

The most useful direct comparison is the STEP 8 trial, which compared:

• semaglutide 2.4 mg once weekly
• liraglutide 3.0 mg once daily

After 68 weeks:

• people on semaglutide lost about 15.8% of body weight on average
• people on liraglutide lost about 6.4% on average

That is a large difference.

What that means in plain language

If the main question is, “Which GLP-1 tends to deliver more weight loss in trials?” the evidence points clearly toward semaglutide over liraglutide.

That does not mean every individual will lose that exact amount. But on average, semaglutide has been the stronger weight-loss medicine in published comparative research.

Why the Ozempic vs Saxenda comparison can be a bit misleading

There is one subtle but important issue here.

The strongest weight-loss comparison data for semaglutide comes from the 2.4 mg obesity dose used in Wegovy, not from the lower diabetes-dose framing most people associate with Ozempic.

So when articles say “Ozempic beats Saxenda for weight loss,” what they often really mean is:

• semaglutide as a molecule produced greater weight loss than liraglutide
• especially at the 2.4 mg once-weekly obesity-treatment dose

That distinction matters if someone is comparing labels, coverage, or what their clinician will actually prescribe.

What about side effects?

Both medicines commonly cause gastrointestinal side effects, especially during initiation and dose escalation.

Common side effects include:

• nausea
• vomiting
• diarrhea
• constipation
• abdominal pain
• indigestion or reflux-type symptoms

Because both are GLP-1 drugs, the side-effect pattern overlaps a lot.

Is one easier to tolerate?

It depends on the person. In the STEP 8 trial, gastrointestinal adverse events were common in both groups. Some people tolerate daily liraglutide better. Others prefer weekly semaglutide and are willing to manage early nausea for the convenience and stronger average weight-loss effect.

In real life, tolerability often comes down to:

• how slowly the dose is increased
• meal size and food choices
• hydration
• whether the patient stays at a dose longer before escalating

What are the important safety warnings?

Both Ozempic and Saxenda carry important warnings, including:

• possible pancreatitis
• gallbladder problems
• risk of hypoglycemia when used with certain other diabetes medicines
• boxed warning related to thyroid C-cell tumors seen in rodents

Because of the thyroid warning, these drugs are generally avoided in people with:

• personal or family history of medullary thyroid carcinoma (MTC)
• MEN 2

Both labels should also be reviewed carefully in people with significant gastrointestinal symptoms, prior pancreatitis concerns, or special pregnancy planning considerations.

So which one is better?

If you are asking strictly about average weight-loss effectiveness, semaglutide comes out ahead.

If you are asking what is better for you personally, the answer may depend on:

• whether you need a diabetes indication or a weight-management indication
• whether you prefer a weekly or daily injection
• which medicine your insurance covers
• how you tolerate gastrointestinal side effects
• your clinician’s view of your risk factors and history

A practical way to think about it

Here is the simplest comparison:

Bottom line

As of May 8, 2026, the evidence still supports this practical takeaway: semaglutide generally produces more weight loss than liraglutide, while Saxenda remains a legitimate GLP-1 weight-management option for people whose clinical situation, access, or tolerability make it a better fit.

So if the question is “Which is more potent for weight loss?” the answer is usually semaglutide. If the question is “Which is the right medicine for me?” that decision should still be made with your clinician after looking at indication, side effects, convenience, and coverage. Consult your healthcare provider before starting any medication.

Sources

• Ozempic prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s025lbl.pdf
• Saxenda prescribing information: https://www.novo-pi.com/saxenda.pdf
• Wegovy prescribing information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s011lbl.pdf
• Rubino D et al. STEP 8 trial, semaglutide 2.4 mg vs liraglutide 3.0 mg for weight management: https://pubmed.ncbi.nlm.nih.gov/35015037/
• MedlinePlus — liraglutide injection: https://medlineplus.gov/druginfo/meds/a611003.html
• MedlinePlus — semaglutide injection: https://medlineplus.gov/druginfo/meds/a618008.html